Login

Megan Baldwin, CEO, Opthea Ltd 00:00:00

Share On Facebook Share On Twitter

Opthea with Proactive at the ASX Small and Mid-Cap Conference

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Stephen Gunnion, CEO, RELIEF THERAPEUTICS Holding
00:10:00
Dr. Martin Enderle, CEO of Scout24 Group.
00:10:00
Liontown Resources' Rapid Growth and Milestones: Managing Director David Richards at the One-to-One Conference
00:10:00
Blue Sky Uranium Fast-Tracks Avana Project in Argentina with $160M JV to Unlock Near-Term, Low-Cost Uranium-Vanadium Production|Nikolaos Cacos,CEO,Blue Sky Uranium Corp
00:10:00
helping our portfolio companies grow their businesses and our operating teams|David Haber,General Partner,Andreessen Horowitz
00:10:00
Innovating Real Estate: JLL's Approach to Technology, Transparency, and Geopolitical Challenges | Christian Ulbrich, CEO, JLL.
00:10:00
Singular Asset Management celebrates six years of a fruitful partnership with Oaktree, sharing their vision and distributing investment products.
00:10:00
Bill.com CEO René Lacerte Discusses Company's Outlook on CNBC's TechCheck | René Lacerte - CEO of BILL
00:10:00
NC BioTech CEO Doug Edgeton on Life Sciences Innovations | DOUG EDGETON, PRESIDENT AND CEO OF NORTH CAROLINA BIOTECHNOLOGY CENTER
00:10:00
Dan Symons President & Chief Executive Officer of C3 Metals
00:10:00
North Island Project Update: Significant Resource Growth and Exploration Plans
00:10:00
Derek Hensley - Wealth Advisor and Host of "Understanding Identity Theft Protection" Webinar | Derek Hensley - Wealth Advisor of Sound Stewardship, LLC

© 2017 - Neuhu+